test44
https://www.cytel.com/blog/using-bayesian-networks-to-predict-survival-outcomes-new-case-study
April 2, 2021
Earlier this month, my colleagues at Cytel Canada published a paper in JCO Clinical Cancer Informatics, offering a..
Read article
test44
https://www.cytel.com/blog/managing-risk-in-clinical-development
March 5, 2020
Generating high-quality clinical data is a vital but challenging task in modern drug development. Unfortunately, in the..
Read article
test44
https://www.cytel.com/blog/unlock-the-power-of-your-clinical-data-with-these-five-top-tips
February 20, 2020
It is widely acknowledged among drug developers that one of their most important assets is the data generated during..
Read article
test44
https://www.cytel.com/blog/a-fresh-approach-to-your-clinical-data-strategyis-your-data-strategy-set-up-to-tackle-key-challenges-in-early-clinical-development-ebook
February 6, 2020
In clinical development, a high-quality evidence package is a prerequisite for a new therapy to gain approval from..
Read article
test44
https://www.cytel.com/blog/a-fresh-approach-to-your-clinical-data-strategy-ebook
January 22, 2020
In the quest for clinical success, we all strive for evidence packages of the highest quality. If the clinical data is..
Read article
